Cardiac rhabdomyomas in tuberous sclerosis complex show apoptosis regulation and mTOR pathway abnormalities

Pediatric and Developmental Pathology

Volumn 12, Issue 2, 2009, Pages 89-95

  Kotulska, Katarzyna ^a   Larysz bRYSZ, Magdalena ^b   Grajkowska, Wiesława ^a   Jóźwiak, Jarosław ^c   Włodarski, Pawet ^c   Sahin, Mustafa ^d   Lewin kowalik, Joanna ^b   Ska pakieŁa, Dorota Domań ^a   Jóźwiak, Sergiusz ^a  

^a CHILDREN'S MEMORIAL HEALTH INSTITUTE   (Poland)

^b MEDICAL UNIVERSITY OF SILESIA   (Poland)

^c MEDICAL UNIVERSITY OF WARSAW   (Poland)

^d BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Apoptosis; Cardiac tumor; mTOR signaling; Tuberous sclerosis complex

Indexed keywords

HAMARTIN; INITIATION FACTOR 4E BINDING PROTEIN 1; KI 67 ANTIGEN; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHOAKT PROTEIN; PHOSPHOEXTRACELLULAR SIGNAL REGULATED MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN KINASE B; S6 KINASE; S6 KINASE 1; TUBERIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CHILD; CONTROLLED STUDY; HEART RHABDOMYOMA; HEART TUMOR; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFANT; NEWBORN; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHABDOMYOMA; TUBEROUS SCLEROSIS; WESTERN BLOTTING;

APOPTOSIS; BLOTTING, WESTERN; CHILD, PRESCHOOL; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HEART NEOPLASMS; HUMANS; INFANT; INFANT, NEWBORN; PROTEIN KINASES; RHABDOMYOMA; TUBEROUS SCLEROSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 63449100787     PISSN: 10935266     EISSN: 16155742     Source Type: Journal    
DOI: 10.2350/06-11-0191.1     Document Type: Article

References (26)

1. Freedom RM, Lee KJ, MacDonald C, Taylor G. Selected aspects of cardiac tumors in infancy and childhood. Pediatr Cardiol 2000;21: 299-316.
2. Becker AE. Primary heart tumors in the pediatric age group: a review of salient pathologic features relevant for clinicians. Pediatr Cardiol 2000;21:317-323.
3. Jozwiak S, Domańska-Pakieła D, Kwiatkowski DJ, Kotulska K. Multiple cardiac rhabdomyomas as a sole symptom of tuberous sclerosis complex: case report with molecular confirmation. J Child Neurol 2005;20:988-989.
4. Tworetzky W, McElhinney DB, Margossian R, et al. Association between cardiac tumors and tuberous sclerosis in the fetus and neonate. Am J Cardiol 2003;92:487-489.
5. Jóźwiak S, Kotulska K, Kasprzyk-Obara J, et al. Clinical and genotype studies of cardiac tumors in 154 patients with tuberous sclerosis complex. Pediatrics 2006;118:1146-1151.
6. Jóźwiak S, Kawalec W, DluZewska J, Daszkowska J, Mirkiewicz- Malek M, Michalowicz R. Cardiac tumours in tuberous sclerosis: their incidence and course. Eur J Pediatr 1994;153:155-157.
7. Dabora SL, JoZwiak S, Franz DN, et al. Mutational analysis in a cohort of 224 Tuberous Sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs. Am J Hum Genet 2001;68:64-80.
8. Webb DW, Fryer AE, Osborne JP. Morbidity associated with tuberous sclerosis: apopulationstudy. DevMedChildNeurol 1996;38:146-155.
9. Fesslova V Villa L, Rizzuti T, Mastrangelo M., Mosca F. Natural history and long-term outcome of cardiac rhabdomyomas detected prenatally. Prenat Diagn 2004;24:241-248.
10. Shepherd CW, Gomez MR, Crowson CS. Causes of death in patients with tuberous sclerosis. Mayo Clin Proc 1991;66:792-796.
11. Jóźwiak J, Jóźwiak S, Grzela T, Łazarczyk M. Positive and negative regulation of TSC2 activity and its effects on downstream effectors of the mTOR pathway. Neuromolecular Med 2005;7:287-296.
12. Roach ES, Gomez MR, Northrup H. Tuberous Sclerosis Complex Consensus Conference: revised clinical diagnostic criteria. J Child Neurol 1998;13:624-628.
13. Vinaitheerthan M, Wei J, Mizuguchi M, Greco A, Barness AG. Tuberous sclerosis: immunohistochemistry expression of tuberin and hamartin in a 31-week gestational fetus. Fetal Pediatr Pathol 2004;23: 241-249.
14. Wei J, Li P, Chiriboga L, et al. Tuberous sclerosis in a 19-week fetus: immunohistochemical and molecular study of hamartin and tuberin. Pediatr Dev Pathol 2002;5:448-464.
15. Mizuguchi M, Kato M, Yamanouchi H, Ikeda K, Takashima S. Tuberin immunohistochemistry in brain, kidneys and heart with or without tuberous sclerosis. Acta Neuropathol 1997;94:25-31.
16. Dan HC, Sun M, Yang L, et al. Phosphatidylinositol 3-kinase/Akt pathway regulates tuberous sclerosis tumor suppressor complex by phosphorylation of tuberin. J Biol Chem 2002;277:35364-35370.
17. Ma L, Chen Z, Erdjument-Bromage H, Tempst P, Pandolfi PP. Phosphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosis and cancer pathogenesis. Cell 2005;121:179-193.
18. Wlodarski P, Kasprzycka M, Liu X, et al. Activation of mammalian target of rapamycin in transformed B lymphocytes is nutrient dependent but independent of Akt, mitogen-activated protein kinase/ extracellular signal-regulated kinase kinase, insulin growth factor-I, and serum. Cancer Res 2005;65:7800-7808.
19. Fisher SA, Langille BL, Srivastava D. Apoptosis during cardiovascular development. Circ Res 2000;87:856-864.
20. Condorelii G, Morisco C, Stassi G, et al. Increased cardiomyocyte apoptosis and changes in proapoptotic and antiapoptotic genes bax and bcl-2 during left ventricular adaptation to chronic pressure overload in the rat. Circulation 1999;99:3071-3078.
21. Latif N, Khan MA, Birks E, et al. Upregulation of the Bcl-2 family of proteins in end stage of heart failure. J Am Coll Cardiol 2000;35: 1769-1777.
22. Adams JM, Cory S. The Bcl-2 protein family: arbiters of cell survival. Science 1998;281:1322-1326.
23. Freilinger A, Rosner M, Krupitza G, et al. Tuberin activates the proapoptotic molecule BAD. Oncogene 2006;25:6467-6479.
24. Freilinger A, Rosner M, Hengstschlager M. Tuberin negatively affects BCL-2's cell survival function. Amino Acids 2006;30:391-396.
25. Franz DN, Leonard J, Tudor C, et al. Rapamycin causes regression of astrocytomas in tuberous sclerosis complex. Ann Neurol 2006;59: 490-498.
26. Jóźwiak J, Jóźwiak S, Ołdak M. Molecular activity of sirolimus and its possible application in tuberous sclerosis treatment. Med Res Rev 2006;26:160-180.